Current:Home > MarketsBillions in NIH grants could be jeopardized by appointments snafu, Republicans say-Angel Dreamer Wealth Society D1 Reviews & Insights
Billions in NIH grants could be jeopardized by appointments snafu, Republicans say
View Date:2024-12-23 23:56:14
The Biden administration allegedly failed to correctly reappoint more than a dozen top-ranking National Institutes of Health leaders, House Republicans say, raising questions about the legality of billions in federal grants doled out by those officials over the last year.
Their claim, detailed Friday in a letter to Health and Human Services Secretary Xavier Becerra, obtained by CBS News, follows a monthslong probe led by Rep. Cathy McMorris Rodgers, the Republican chair of the House Energy & Commerce Committee, into vacancies at the agency.
"The failure to reappoint the above NIH IC Directors jeopardizes the legal validity of more than $25 billion in federal biomedical research grants made in 2022 alone," the committee wrote.
- House Energy & Commerce Committee letter to HHS Secretary Xavier Becerra
- Letter attachments
The Biden administration rebutted the GOP-led committee's accusations that it ran afoul of the law. An HHS official familiar with the matter, who responded on the condition of anonymity, said the committee was misrepresenting the requirements.
The committee's letter stems from the 21st Century Cures Act passed in 2016, which says that directors atop the institutes and centers within the NIH have five-year term limits before they must be reappointed.
When the term limits of 14 of these officials came due at the end of 2021, the Biden administration says the NIH director correctly reappointed them. The law says that they must be "appointed by the Secretary, acting through the Director of the National Institutes of Health."
The committee says that the way those officials were reappointed falls short of what the law demands from Becerra himself.
"Specifically, it requires the Secretary of HHS to reappoint NIH IC Directors, including those who were serving at the time of the law's enactment when their five-year terms expired on December 12, 2021," the letter stated.
After the committee's probe was launched, Becerra signed affidavits the department says retroactively ratified and adopted the appointments.
While the Biden administration thinks its grants remain on sound footing, the HHS official said Becerra's affidavits were intended to bolster defenses against challenges that might upend them in the courts.
The committee questioned the legality of that move. Among the issues it flagged were the retirements of Dr. Anthony Fauci, formerly head of the National Institutes of Allergy and Infectious Diseases, and Dr. Roger Glass, who had headed the Fogarty International Center. Both stepped down months before Becerra signed the affidavits in June.
"HHS and the NIH should have known within days of receiving the Committee's March 14, 2022, letter that the reappointments as legally required had not occurred. Rather than addressing the problem in consultation with the Committee, HHS and the NIH repeatedly misled the Committee," the committee wrote of its monthslong back-and-forth with the department.
The HHS official insisted that the department had cooperated with the committee's questions in good faith, voluntarily producing documents and responses to the inquiry.
After CBS News published this story, an HHS spokesperson provided an on-the-record statement Monday saying: "The Committee's allegations are clearly politically motivated and lack merit. As their own report shows, the prior administration appointed at least five NIH IC officials under the process they now attack. The Department stands by the legitimacy of these NIH IC Directors' reappointments."
Thousands of researchers compete every year for NIH funding, which support a variety of projects ranging from fundamental laboratory research to human clinical trials.
Asked how those programs might be affected, a committee aide told CBS News, "It is unclear what the impact will be, but it creates unnecessary uncertainty and opens the door to legal challenges, While we are unaware of any other Cabinet Secretaries committing such egregious process violations, a similar case involving SEC Administrative Law Judges required the decisions made by improperly appointed officials be relitigated in front of a legally appointed judge."
The committee says its probe into the issue is continuing and prompted a renewed round of questions to the department, as well as the possibility of demanding interviews from HHS and NIH officials.
Its letter to Becerra warned that "intentional misstatements or omissions" may constitute "federal criminal violations under 18 USC 1001," adding that it serves as a formal request to preserve "all existing and future records."
"Institute directors with discretion to award billions or even hundreds of millions in research funding are, by definition, exercising significant authority pursuant to the laws of the United States. As such, institute directors are the quintessential 'inferior officers,'" a former senior HHS official told CBS News.
"The Secretary cannot delegate his or her constitutional authority to appoint inferior officers. It is my understanding that prior administrations of both parties zealously guarded the appointments process and took care to ensure that inferior officers were properly appointed," said the former senior official, who previously served in the Bush, Reagan and Trump administrations.
The Republican-led committee's letter comes as the Biden administration has yet to fill key vacancies in the NIH leadership.
The agency has been without a director since December 2021, when Dr. Francis Collins stepped down from his post.
In May, President Biden announced he planned to nominate Dr. Monica Bertagnolli — currently head of the NIH's National Cancer Institute — to fill the role.
So far, Bertagnolli's nomination is awaiting Senate confirmation.
Independent Sen. Bernie Sanders, chair of the panel charged with signing off on HHS nominees, has vowed not to move forward with the nomination without new pledges from the Biden administration on drug prices.
"I will oppose all nominations until we have a very clear strategy on the part of the government … as to how we're going to lower the outrageously high cost of prescription drugs," Sanders told The Washington Post last month.
- In:
- United States Department of Health and Human Services
- Biden Administration
- Republican Party
- United States House of Representatives
Catherine Herridge is a senior investigative correspondent for CBS News covering national security and intelligence based in Washington, D.C.
TwitterveryGood! (8982)
Related
- Tuskegee University closes its campus to the public, fires security chief after shooting
- Police investigate death of girl whose body was found in pipe after swimming at a Texas hotel
- Youngkin acts on gun bills, vetoing dozens as expected, amending six and signing two pairs
- Trial date set in August for ex-elected official accused of killing Las Vegas journalist
- AP Top 25: Oregon remains No. 1 as Big Ten grabs 4 of top 5 spots; Georgia, Miami out of top 10
- What to know about the Francis Scott Key Bridge collapse in Baltimore that left at least 6 presumed dead
- WWII ace pilot Richard Bong's plane crashed in 1944. A team has launched a search for the wreckage in the South Pacific.
- Sleek Charging Stations that Are Stylish & Functional for All Your Devices
- Does the NFL have a special teams bias when hiring head coaches? History indicates it does
- Of course Aaron Rodgers isn't a VP candidate. Jets QB (and his conspiracies) stay in NFL
Ranking
- Todd Golden to continue as Florida basketball coach despite sexual harassment probe
- Pregnant Chick-fil-A manager killed in crash with prison transport van before baby shower
- Influencer Jackie Miller James Shares Aphasia Diagnosis 10 Months After Aneurysm Rupture
- Hold Tight to These Twilight Cast Reunion Photos, Spider Monkey
- 'Yellowstone' premiere: Record ratings, Rip's ride and Billy Klapper's tribute
- How to watch surprise 5th episode of 'Quiet on Set' featuring Drake Bell and other stars
- Youngkin acts on gun bills, vetoing dozens as expected, amending six and signing two pairs
- New Mexico regulators worry about US plans to ship radioactive waste back from Texas
Recommendation
-
Young Black and Latino men say they chose Trump because of the economy and jobs. Here’s how and why
-
Sister Wives' Hunter Brown Shares How He Plans to Honor Late Brother Garrison
-
Fast food workers are losing their jobs in California as new minimum wage law takes effect
-
2 brothers attacked by mountain lion in California 'driven by nature', family says
-
Amazon launches an online discount storefront to better compete with Shein and Temu
-
Lawsuit says Ohio’s gender-affirming care ban violates the state constitution
-
Watch livestream: President Joe Biden gives remarks on collapse of Baltimore's Key Bridge
-
Christine Quinn's Husband Christian Dumontet Denies Assault While Detailing Fight That Led to 911 Call